Does metabolic syndrome influence the efficacy of mirabegron treatment in female patients with overactive bladder?

Manami KinjoKazuki MasudaYu NakamuraSatoru TaguchiMitsuhiro TamboHiroshi Fukuhara

Published in: International urogynecology journal (2022)

Mirabegron is effective in patients with and without MS, and comorbid hyperglycemia and severe OAB symptoms before treatment are predictors of the efficacy of mirabegron treatment.

Keyphrases

metabolic syndrome
type diabetes
multiple sclerosis
mass spectrometry
cardiovascular disease
combination therapy
adipose tissue
early onset
ms ms
insulin resistance
skeletal muscle
depressive symptoms
replacement therapy
smoking cessation
sleep quality